1.Message from the Founder

Welcome to Runyi New Material (www.runyinewmat.com).

Pucheng is located at the geographic center of China, connecting the east and west, the north and south. Runyi New Material was born here and started its journey here. We chose this land not only for its rich resources and mature industrial infrastructure, but also for its spirit of hard work and enterprise.

The chemical industry is the backbone of the national economy, and it is also the field where our team has over 30 years of deep experience. Though Runyi is a young company, our team possesses profound technical expertise and proven industrialization capabilities. From our first workshop to a 5.000-ton annual capacity modern facility, from a single intermediate to over 200 product pipelines covering pharmaceuticals, optoelectronics and beyond, we have always held one belief: solving critical material bottlenecks with technological innovation, and earning long-term trust from global customers through open collaboration.

Today, the global fine chemical industry is undergoing profound transformation. Green processes, smart manufacturing, and CDMO models are reshaping the competitive landscape. Runyi will maintain strategic focus, adhering to the business philosophy of “deep collaboration and innovation-driven growth.” We aim to form a true shared future with our customers, building capabilities through consistent delivery and creating value through mutual growth.

We deeply understand that the vitality of a chemical enterprise stems not only from technology and capacity, but also from respect for safety, environmental protection, and business ethics. Runyi will operate this business in a transparent, compliant, and responsible manner – living up to the dedication of our employees, the trust of our partners, and the opportunities of our time.

We sincerely invite colleagues from around the world to visit Pucheng and explore cooperation together.

Zhang Wei

Founder

Runyi New Material Technology Company Limited

2.Company Profile

Founded in 2023. Runyi New Material Technology Company Limited is a national high-tech enterprise specializing in fine chemical intermediates and new materials.

The company is located in Shaanxi Pucheng Industrial Park — a provincial-level key county-level industrial cluster, a core base of Shaanxi“13115”Science & Technology Innovation Project, and a low-carbon pilot zone. The park spans a planned area of 16.84 km², hosting integrated clusters in new materials, fine chemicals, and other strategic sectors.

Runyi New Material has invested in and constructed the “Runyi 5.000 Tons Annual Fine Chemical Intermediates Project” in Pucheng. Our products are widely used in high-growth sectors such as pharmaceuticals, optoelectronic materials, and biopharmaceuticals.

Guided by our core business philosophy of “Deep Collaboration & Innovation-Driven Growth,” we are committed to building a “shared future” strategic alliance with our customers, enabling a seamless transition from customized R&D to industrial production.

Looking ahead, Runyi New Material will continue to leverage its strong capital base and advanced manufacturing facilities to enhance independent innovation and precision manufacturing capabilities. Our goal is to become a trusted and innovative partner in the global fine chemical value chain.

3.Establishment Background:

To meet the growing global and domestic demand for high-performance fine chemical intermediates, Pucheng Runyi New Material Technology Company Limited was officially established in 2023 and launched the “5.000 Tons Annual Fine Chemical Intermediates Project.”

The implementation of this project is based on the following strategic assessments:

●Industry Opportunity: The peak expiration of global patent drugs is driving growth in the generics and intermediates market, while the localization of optoelectronic display materials is accelerating. These trends offer significant room for growth.

●Location Advantage: As a provincial-level key low-carbon pilot park in Shaanxi, Pucheng Industrial Park provides robust infrastructure, environmental support, and policy frameworks, ensuring compliant execution and long-term operation of chemical projects.

●Team Expertise: The core team brings an average of over 15 years of experience in R&D, production, and management across the fine chemical sector, with proven capabilities spanning from lab process development to thousand-ton-scale industrialization.

The founding of Runyi is not only an industrial investment but also a proactive response to the national imperative of localizing critical materials.

4.Vision & Mission:

Vision:

To become an innovative enterprise with core competitiveness and social responsibility in the global fine chemical industry.

Mission:

Driven by technological innovation to accelerate industrial upgrading, we provide customers with high-quality, highly reliable fine chemical products and solutions. We are committed to advancing the localization of critical materials in pharmaceuticals, optoelectronics, and other key sectors, while contributing to the sustainable development of the industry.

5.Core Values:

Integrity:

Treat every customer, supplier, and partner with honesty, transparency, and responsibility. We mean what we say, and we deliver on our promises.

Collaboration:

Form a “shared future” with our customers, deeply embedding ourselves into their R&D and supply chain systems — creating value through synergy and sharing success through co-creation.

Shared Growth:

Share development opportunities with employees, share technological achievements with partners, and share business benefits with society.

Honor:

Treasure every trust. We regard customer recognition, industry respect, and social reputation as our company’s most valuable assets.

6.Development Strategy:

Short-term (1-3 years)

Complete process optimization and capacity ramp-up for core products including 2.4.6-trichloroaniline and 2.7-dihydroxy-9-fluorenone, establishing a leading position in niche market share.

● Achieve ISO 9001. ISO 14001. and ISO 45001 system certifications, and initiate supplier audit by at least one major international pharmaceutical company.

● Maintain R&D spending at no less than 8% of revenue, initially forming a technology platform characterized by hydrogenation, coupling, and low-temperature reactions.

Mid-term (3-5 years)

● Extend product portfolio from intermediates to advanced intermediates and simple APIs, increasing project value.

● Establish stable CDMO partnerships with 5-10 innovative drug companies (both domestic and international), transitioning from a “product sales” to a “technical service” business model.

●Build a green synthesis process R&D center, reducing waste emission intensity by 30% compared to the initial plant start-up phase.

Long-term (5-10 years)

●Develop benchmark capabilities in frontier technologies such as continuous flow manufacturing, biocatalysis, and AI-assisted synthesis.

●Complete business and technical support node deployment in major European and U.S. markets, achieving global operations.

●Strategically extend either upstream into key starting materials or downstream into formulations as opportunities arise, building end-to-end industrial chain synergy.